Clinical Trial Update: Endostar First-line Treatment of Advanced Non-small Cell Lung Squamous Carcinoma [Phase 4]

View source ↗

Summary

This document provides an update on a Phase 4 clinical trial evaluating Endostar (recombinant human endostatin) as first-line treatment for advanced non-small c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Endostar (recombinant human endostatin)

Snippet

Sponsor: Nanjing NingQi Medicine Science and Technology Co., Ltd. | Conditions: Advanced Lung Squamous Carcinoma | Phase 4 | Status: UNKNOWN